SCHEMBL24352260

SCHEMBL24352260

CC(C)NCc1c(F)cccc1-c1cnccn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TERT O14746 2/20 0.41
▸ CASP6 P55212 1/20 0.40
▸ ALOX5AP P20292 2/20 0.39
▸ FEN1 P39748 2/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ PIEZO1 Q92508 1/20 0.38
▸ ADRA1D P25100 1/20 0.38
▸ ADRA1A P35348 1/20 0.38
▸ ADRA1B P35368 1/20 0.38
▸ GRIN2B Q13224 1/20 0.37
▸ PIM1 P11309 1/20 0.37
▸ GPBAR1 Q8TDU6 1/20 0.36
▸ HDAC4 P56524 2/20 0.35
▸ PKM P14618 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24352486 0.85 TERT (0.43) TERTCASP6ALOX5APFEN1NPC1
SCHEMBL24352407 0.82 CASP6 (0.40) CASP6GRIN2BGPBAR1HDAC4EED
SCHEMBL24352918 0.80 GRIN2B (0.38) GRIN2BPIM1HTTATMNPSR1
SCHEMBL24352866 0.80 ALOX5AP (0.42) ALOX5APFEN1GRIN2BPIM1HTT
SCHEMBL24352815 0.79 GRIN2B (0.40) CASP6GRIN2BGPBAR1HTTATM
SCHEMBL24352279 0.78 ADRA1A (0.43) CASP6ALOX5APFEN1NPC1ALDH1A1
SCHEMBL24352258 0.77 CASP6 (0.39) CASP6GRIN2BGPBAR1HDAC4HTT
SCHEMBL7130078 0.74 GRIN2B (0.47) ALDH1A1SMN1; SMN2GRIN2BHTTATM
SCHEMBL24352814 0.72 GRIN2B (0.38) NPC1ALDH1A1SMN1; SMN2GRIN2BHTT
SCHEMBL16640381 0.72 ALOX5AP (0.47) TERTCASP6ALOX5APFEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220119395-A1 BICYCLIC COMPOUNDS ALIGOS THERAPEUTICS, INC. 2022-04-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220119395-A1 BICYCLIC COMPOUNDS SLC10A1, PKD1, CYP11B2 TERT 3412/4885CASP6 2981/4885ALOX5AP 3394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback